In our study, we proposed that the interaction between CD155 and SRC resulted in augmented SRC activation by disrupting the intramolecular interaction that held SRC in a close molecular structure, representing a new mechanism for the abnormal activation of SRC in HCC. The gene discussed is SRC; the disease is hepatocellular carcinoma.